DENIA CANETA: Open Payments
NPI 1558922328 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,901 in 94 payments from 35 companies in 2025. Trend: 2023 $2,247 · 2024 $3,660 · 2025 $2,901
Food & beverage: $2,692Education: $209
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $270 |
| Tempus AI, Inc | 6 | $222 |
| Incyte Corporation | 5 | $205 |
| Astellas Pharma US Inc | 4 | $200 |
| Lilly USA, LLC | 6 | $193 |
| ABBVIE INC. | 9 | $190 |
| GENZYME CORPORATION | 5 | $162 |
| Gilead Sciences, Inc. | 2 | $150 |
| Madrigal Pharmaceuticals | 3 | $136 |
| Exelixis Inc. | 4 | $106 |
Products named: XT CDX, Monjuvi, Trodelvy, REZDIFFRA, Enhertu, CABOMETYX, Vonjo, DATROWAY.
Industry payments across CA — which companies pay providers there.
